Work

Phase I study of combination of pasireotide (SOM 230) plus gemcitabine in metastatic pancreatic cancer (MPC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e15075

Authors: Richard D. Kim, Helen Jump, Dung-Tsa Chen, William J. Fulp, David Shibata, Erin Siegel, Gregory M. Springett

Institution: Moffitt Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600835888

Cites:

Cited by:

Related to: 10